33925035|t|A Soluble Epoxide Hydrolase Inhibitor, 1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis.
33925035|a|Polyunsaturated fatty acids (PUFAs) are essential FAs for human health. Cytochrome P450 oxygenates PUFAs to produce anti-inflammatory and pain-resolving epoxy fatty acids (EpFAs) and other oxylipins whose epoxide ring is opened by the soluble epoxide hydrolase (sEH/Ephx2), resulting in the formation of toxic and pro-inflammatory vicinal diols (dihydroxy-FAs). Pharmacological inhibition of sEH is a promising strategy for the treatment of pain, inflammation, cardiovascular diseases, and other conditions. We tested the efficacy of a potent, selective sEH inhibitor, 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), in an animal model of multiple sclerosis (MS), experimental autoimmune encephalomyelitis (EAE). Prophylactic TPPU treatment significantly ameliorated EAE without affecting circulating white blood cell counts. TPPU accumulated in the spinal cords (SCs), which was correlated with plasma TPPU concentration. Targeted lipidomics in EAE SCs and plasma identified that TPPU blocked production of dihydroxy-FAs efficiently and increased some EpFA species including 12(13)-epoxy-octadecenoic acid (12(13)-EpOME) and 17(18)-epoxy-eicosatrienoic acid (17(18)-EpETE). TPPU did not alter levels of cyclooxygenase (COX-1/2) metabolites, while it increased 12-hydroxyeicosatetraenoic acid (12-HETE) and other 12/15-lipoxygenase metabolites. These analytical results are consistent with sEH inhibitors that reduce neuroinflammation and accelerate anti-inflammatory responses, providing the possibility that sEH inhibitors could be used as a disease modifying therapy, as well as for MS-associated pain relief.
33925035	39	98	1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea	Chemical	-
33925035	112	153	Experimental Autoimmune Encephalomyelitis	Disease	MESH:D004681
33925035	155	182	Polyunsaturated fatty acids	Chemical	MESH:D005231
33925035	184	189	PUFAs	Chemical	MESH:D005231
33925035	213	218	human	Species	9606
33925035	227	242	Cytochrome P450	Gene	4051
33925035	254	259	PUFAs	Chemical	MESH:D005231
33925035	276	288	inflammatory	Disease	MESH:D007249
33925035	293	297	pain	Disease	MESH:D010146
33925035	308	325	epoxy fatty acids	Chemical	-
33925035	327	332	EpFAs	Chemical	-
33925035	344	353	oxylipins	Chemical	MESH:D054883
33925035	360	367	epoxide	Chemical	MESH:D004852
33925035	417	420	sEH	Gene	2053
33925035	421	426	Ephx2	Gene	2053
33925035	473	485	inflammatory	Disease	MESH:D007249
33925035	486	499	vicinal diols	Chemical	-
33925035	501	514	dihydroxy-FAs	Chemical	-
33925035	547	550	sEH	Gene	2053
33925035	596	600	pain	Disease	MESH:D010146
33925035	602	614	inflammation	Disease	MESH:D007249
33925035	616	639	cardiovascular diseases	Disease	MESH:D002318
33925035	709	712	sEH	Gene	2053
33925035	724	783	1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea	Chemical	-
33925035	785	789	TPPU	Chemical	-
33925035	814	832	multiple sclerosis	Disease	MESH:D009103
33925035	834	836	MS	Disease	MESH:D009103
33925035	839	880	experimental autoimmune encephalomyelitis	Disease	MESH:D004681
33925035	882	885	EAE	Disease	MESH:D004681
33925035	901	905	TPPU	Chemical	-
33925035	942	945	EAE	Disease	MESH:D004681
33925035	1001	1005	TPPU	Chemical	-
33925035	1078	1082	TPPU	Chemical	-
33925035	1121	1124	EAE	Disease	MESH:D004681
33925035	1156	1160	TPPU	Chemical	-
33925035	1183	1196	dihydroxy-FAs	Chemical	-
33925035	1228	1232	EpFA	Chemical	-
33925035	1251	1281	12(13)-epoxy-octadecenoic acid	Chemical	-
33925035	1283	1295	12(13)-EpOME	Chemical	-
33925035	1301	1333	17(18)-epoxy-eicosatrienoic acid	Chemical	-
33925035	1335	1347	17(18)-EpETE	Chemical	MESH:C070378
33925035	1350	1354	TPPU	Chemical	-
33925035	1395	1402	COX-1/2	Gene	4512;4513
33925035	1436	1467	12-hydroxyeicosatetraenoic acid	Chemical	MESH:D019377
33925035	1469	1476	12-HETE	Chemical	MESH:D019377
33925035	1488	1506	12/15-lipoxygenase	Gene	246
33925035	1565	1568	sEH	Gene	2053
33925035	1592	1609	neuroinflammation	Disease	MESH:D000090862
33925035	1630	1642	inflammatory	Disease	MESH:D007249
33925035	1685	1688	sEH	Gene	2053
33925035	1761	1763	MS	Disease	MESH:D009103
33925035	1775	1779	pain	Disease	MESH:D010146
33925035	Association	MESH:D007249	2053
33925035	Association	MESH:D007249	4051
33925035	Association	MESH:D000090862	2053
33925035	Association	MESH:D010146	4051
33925035	Association	MESH:D054883	MESH:D010146
33925035	Association	MESH:D054883	4051
33925035	Association	MESH:D005231	4051
33925035	Association	MESH:D002318	2053
33925035	Association	MESH:D010146	2053
33925035	Association	MESH:D009103	2053

